Dr. Wei Cao is the founder, chairman and CEO of Gracell Biotechnologies Co. Ltd.

Dr. Cao has over 30 years of professional experience in scientific research, products development and startups. He was the co-founder and CEO of Cellular Biomedicine Group Inc., which is currently the only Chinese (stem) cell companylisted on NASDAQ. Dr. Cao served as Technical Manager for Bayer Diagnostics Asia Pacific Region, President of Wuxi New District Hospital and China General Manager of Affymetrix, a world leader in genetic analysis industry.

Dr. Cao earned a Bachelor degree in Medicine from Fudan University Medical College and a PhD degree in pharmacology from Medical College of Virginia. He has extensive research experience in  immune-pharmacology field at Harvard Medical School and Stanford University Medical Center. He has been invited as Guest Scientist by Department of Histology and Embryology of Fudan University Medical College, appointed asthe member of  International Cellular Medicine Society/Committee of Standards for the Practice of Cell-Based Medicine (AABB), elected as the member of Expert Committee of Regenerative Medicine and Cell Therapy Clinical Application of Chinese Medical Doctor Association (CMDA) and Director of International Chinese Stem Cell Foundation (ICSCF).

Dr. Cao received prestigious White Magnolia Award from Shanghai City for his contribution to international collaboration and economic development of the city.